Humana Inc. (NYSE:HUM) Plans $0.89 Quarterly Dividend

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, February 19th. Shareholders of record on Friday, March 27th will be paid a dividend of 0.885 per share by the insurance provider on Friday, April 24th. This represents a c) annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Friday, March 27th.

Humana has increased its dividend payment by an average of 0.1%annually over the last three years. Humana has a dividend payout ratio of 24.1% indicating that its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $13.13 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 27.0%.

Humana Trading Up 1.9%

Shares of HUM stock traded up $3.49 during trading hours on Thursday, reaching $190.61. The company had a trading volume of 1,652,285 shares, compared to its average volume of 2,358,240. Humana has a 1-year low of $169.61 and a 1-year high of $315.35. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.02. The firm has a market cap of $22.92 billion, a price-to-earnings ratio of 19.41, a P/E/G ratio of 1.98 and a beta of 0.44. The company has a 50 day moving average of $240.52 and a 200 day moving average of $259.61.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $32.08 billion. During the same quarter in the prior year, the company posted ($2.16) earnings per share. The firm’s revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities research analysts anticipate that Humana will post 16.47 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HUM. TD Cowen dropped their price objective on Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a research note on Friday, February 13th. Guggenheim lowered their price target on Humana from $312.00 to $252.00 and set a “buy” rating for the company in a report on Thursday, February 12th. UBS Group cut their price objective on Humana from $285.00 to $195.00 and set a “neutral” rating on the stock in a report on Thursday, February 12th. Jefferies Financial Group lowered their target price on Humana from $310.00 to $235.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. Finally, Deutsche Bank Aktiengesellschaft set a $180.00 price objective on shares of Humana and gave the company a “hold” rating in a research report on Friday, February 13th. Seven research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $228.48.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.